Industry News
Cancer cells present at the outset of prostate cancer diagnosis may have implications for earlier treatment and better outcomes
Sep 27, 2013
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer... Read More
In prostate cancer, unstable chromosomes linked to less favorable response to RT and surgery
Sep 27, 2013
Detailed evaluation of a prostate cancer tumor biopsy may predict treatment outcomes for image-guided radiation therapy (IGRT) or surgery for prostate cancer, according to research presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting... Read More
iCAD announces positive three-year data using the Xoft System to treat skin cancer
Sep 27, 2013
iCAD, Inc... Read More
Myriad Genetics' myplan™ lung cancer test meets primary clinical endpoint
Sep 27, 2013
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer death in patients with early-stage, resectable lung adenocarcinoma and may be a valuable tool for selecting which early-stage patients should be considered for additional post-surgical chemotherapy... Read More
A potential new treatment option for patients with brain cancer
Sep 27, 2013
A novel drug for patients with brain cancer, 2B3-101, has shown preliminary positive results. The Dutch biotech to-BBB has developed 2B3-101 and initiated a clinical trial to investigate this new treatment. The Phase I safety results will be presented at the European Cancer Congress 2013 in Amsterdam at the end of September... Read More
Repurposed antidepressants have potential to treat small-cell lung cancer
Sep 27, 2013
A bioinformatics approach to repurposing drugs resulted in identification of a class of antidepressants as a potential new treatment for small-cell lung cancer (SCLC), according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research. Based on data generated using bioinformatics, two drugs approved by the U.S... Read More
Smoking increases risk of complications, death after colorectal surgery and most common procedures
Sep 27, 2013
Infection, pneumonia, blood clots and kidney failure are all possible complications after any major surgery. A new study shows that smoking boosts the risk of such complications following some of the most common colorectal procedures, including surgery for colon cancer, diverticulitis or inflammatory bowel disease... Read More
Cancer cells present at the outset of prostate cancer diagnosis may have implications for earlier treatment and better outcomes
Sep 27, 2013
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer... Read More
In prostate cancer, unstable chromosomes linked to less favorable response to RT and surgery
Sep 27, 2013
Detailed evaluation of a prostate cancer tumor biopsy may predict treatment outcomes for image-guided radiation therapy (IGRT) or surgery for prostate cancer, according to research presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting... Read More
Research shows how medicine for the brain can be absorbed through the nose
Sep 27, 2013
New Danish/Italian research shows how medicine for the brain can be absorbed through the nose. This paves the way to more effective treatment of neurological diseases like Alzheimer's and tumors in the brain. A big challenge in medical science is to get medicine into the brain when treating patients with neurological diseases... Read More
Previous Page Next Page